Start Your NewsReadery Pro FREE TRIAL!
Register and verify your email address to start your
NewsReadery Pro FREE TRIAL
today!
Login / Register
Actions
Newsfeed
Popular
Local
Discover
Follows
Blocks
Bookmarks
Filters
Settings
PowerUps
Help
Updates
Login / Register
prnewswire.com
/
Share Newsitem
View, share or embed this newsitem using the details below.
PR Newswire: press release distribution, targeting, monitoring and marketing
@prnewswire.com
/
16 hours
16h
Follow
YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR
/PRNewswire/ -- YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based...
https://newsreadery.com/go/6c4359b4bf09b4dcc8d5cad50cfdfa93
Save
Share
Share this Newsitem URL
Embed this Newsitem
<div class="readery-embed readery-embed-6c4359b4bf09b4dcc8d5cad50cfdfa93"></div><script async src="https://open.newsreadery.com/oembed?format=html&url=https%3A%2F%2Fnewsreadery.com%2Fitem%2F6c4359b4bf09b4dcc8d5cad50cfdfa93" charset="utf-8"></script>
Back
Read Full Article
Continue
Please wait ...
